From Ideal to Real: Guideline-Based Treatment Decisions for Bladder Cancer in Every Care Setting

This program is supported by an independent education grant from MSD. This online education program has been designed solely for healthcare professionals in the US. The content is not intended for healthcare professionals in any other country. Join leading bladder cancer experts Dr. Petros Grivas and Dr. Benjamin Garmezy for this accredited live online teaching session. Using three progressive, case-based role-play scenarios, this session explores the "ideal vs. real" complexities of managing bladder cancer across diverse practice environments. By adopting specific hospital, community, and rural perspectives, the faculty will illustrate how to translate diagnostic findings into guideline-aligned treatment decisions despite real-world system constraints. Participants will gain practical insights into navigating resource limitations, strengthening multidisciplinary care coordination, and implementing escalation pathways for NMIBC, MIBC, and metastatic disease to ensure consistent, high-quality care in every setting. Credits: AMA PRA Category 1 Credits™ (1.00.00 hours) Session Highlights Navigating High-Risk NMIBC Escalation: Contrast guideline-ideal TURBT and BCG timing with the practical realities of rural care, focusing on safe treatment adaptations when pathology or resection access is limited. Preserving Curative Intent in MIBC: Identify strategies to maintain the cisplatin-to-cystectomy sequence despite systemic barriers, including imaging delays, surgical access gaps, and patient travel constraints. Systemic Therapy & Referral Triggers: Define clear "treat here vs. refer now" criteria for advanced urothelial carcinoma to manage monitoring logistics and follow-up care across diverse clinical settings. Please read the full CE information & disclosures here before joining: https://app.medalleducation.com/event...